ICD-10 Coding for Carcinomatosis(C48.2, C48.2U, C78.6)
Learn about the ICD-10 coding for carcinomatosis, including code C78.6 for peritoneal carcinomatosis, documentation requirements, and coding pitfalls.
Complete code families applicable to Carcinomatosis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C78.6 | Secondary malignant neoplasm of retroperitoneum and peritoneum | Use when there is a confirmed secondary malignant neoplasm in the peritoneum. |
|
| C80.1 | Malignant (primary) neoplasm, unspecified | Use when the primary site of the malignancy is unknown. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutCarcinomatosis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Carcinomatosis.
Documenting 'history of cancer' during active treatment.
Impact
Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims.
Mitigation
Ensure documentation reflects current treatment status., Use active treatment codes when applicable.
Using C78.6 without a primary code when primary is known.
Impact
Reimbursement: May lead to incorrect DRG assignment and reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate representation of the patient's condition.
Mitigation
Always link to the primary malignancy code.
Incorrect sequencing of codes
Impact
Primary malignancy codes must precede secondary codes unless the primary is unknown.
Mitigation
Review coding guidelines and ensure proper sequencing.